Travoprost

Travoprost
Systematic (IUPAC) name
propan-2-yl 7-[3,5-dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)
phenoxy]-but-1-enyl]-cyclopentyl]hept-5-enoate
Clinical data
Trade names Travatan
AHFS/Drugs.com monograph
MedlinePlus a602027
Pregnancy cat. C US
Legal status Rx only (US)
Routes Topical (eye drops)
Identifiers
CAS number 157283-68-6 Y
ATC code S01EE04
PubChem CID 5282226
DrugBank APRD01271
ChemSpider 4445407 Y
UNII WJ68R08KX9 Y
KEGG D01964 N
ChEBI CHEBI:746859 N
ChEMBL CHEMBL1200799 N
Chemical data
Formula C26H35F3O6 
Mol. mass 500.548 g/mol
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

Travoprost ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure. It is a synthetic prostaglandin analog (or more specifically, an analog of prostaglandin F)[1][2] that works by increasing the outflow of aqueous fluid from the eyes.[3] It is also known by the brand names of Travatan and Travatan Z, manufactured by Alcon, and Travo-Z, manufactured by Micro Labs.

Side effects

Possible side effects of this medication are:

References

  1. ^ Alcon Laboratories, Inc. (September 2011). "TRAVATAN - travoprost solution". DailyMed. Bethesda, MD: U.S. National Library of Medicine. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=338e7ff4-0d91-4208-a45d-bfa2be52334d. Retrieved 2011-09-30. 
  2. ^ Alcon Laboratories, Inc. (September 2011). "TRAVATAN Z (travoprost) solution". DailyMed. Bethesda, MD: U.S. National Library of Medicine. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5549684b-1724-45ca-b67b-590c62b7c149. Retrieved 2011-09-30. 
  3. ^ AHFS Consumer Medication Information (2011-01-01). "Travoprost Ophthalmic". MedlinePlus. Bethesda, MD: U.S. National Library of Medicine. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a602027.html. Retrieved 2011-09-30.